FRS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.693200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.517200E-01
Normal-vs-Stage2
5.626200E-01
Normal-vs-Stage3
2.722300E-02
Normal-vs-Stage4
9.906400E-01
Stage1-vs-Stage2
3.718600E-01
Stage1-vs-Stage3
6.327500E-02
Stage1-vs-Stage4
9.389600E-01
Stage2-vs-Stage3
6.344100E-03
Stage2-vs-Stage4
5.119000E-01
Stage3-vs-Stage4
4.568000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.668800E-01
Normal-vs-AfricanAmerican
7.854400E-01
Normal-vs-Asian
9.586800E-01
Caucasian-vs-AfricanAmerican
4.497800E-01
Caucasian-vs-Asian
6.077800E-01
AfricanAmerican-vs-Asian
8.020400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.975000E-01
Normal-vs-Female
3.281200E-01
Male-vs-Female
3.934400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.785200E-01
Normal-vs-Age(41-60Yrs)
9.651800E-01
Normal-vs-Age(61-80Yrs)
2.144600E-01
Normal-vs-Age(81-100Yrs)
7.813700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.184800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.308350E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.494000E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.005960E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.843900E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.570600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.022500E-02
Normal-vs-Daily Drinker
6.151600E-02
Normal-vs-Weekly Drinker
1.361430E-01
Normal-vs-Occasional Drinker
7.975400E-01
Normal-vs-Social Drinker
6.751800E-01
Non Drinker-vs-Daily Drinker
5.813000E-01
Non Drinker-vs-Weekly Drinker
4.189200E-01
Non Drinker-vs-Occasional Drinker
6.370000E-02
Non Drinker-vs-Social Drinker
6.747900E-02
Daily Drinker-vs-Weekly Drinker
7.584000E-01
Daily Drinker-vs-Occasional Drinker
8.516300E-02
Daily Drinker-vs-Social Drinker
1.319360E-01
Weekly Drinker-vs-Occasional Drinker
1.094430E-01
Weekly Drinker-vs-Social Drinker
2.327800E-01
Occasional Drinker-vs-Social Drinker
3.270600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.185990E-01
Normal-vs-Grade 2
2.050800E-01
Normal-vs-Grade 3
4.900200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.197000E-01
Grade 1-vs-Grade 3
5.769800E-01
Grade 1-vs-Grade 4
1.185990E-01
Grade 2-vs-Grade 3
3.082800E-01
Grade 2-vs-Grade 4
2.050800E-01
Grade 3-vs-Grade 4
4.900200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.787410E-01
Normal-vs-NonDiabetic
5.944600E-01
Diabetic-vs-NonDiabetic
2.531400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.142290E-02
Normal-vs-NoPancreatitis
6.028800E-01
Pancreatitis-vs-NoPancreatitis
3.662400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.230400E-01
Normal-vs-N1
3.607000E-01
N0-vs-N1
5.704800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.070600E-01
Normal-vs-TP53-NonMutant
7.158800E-01
TP53-Mutant-vs-TP53-NonMutant
9.161200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
